X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-08-12 | GLSI | Thompson Jaye | VP Clinical Reg Affairs | P - Purchase | $13.85 | +800 | 263,148 | 0% | +$11,080 | ||||||
2024-08-02 | GLSI | Thompson Jaye | VP Clinical Reg Affairs | P - Purchase | $15.15 | +1,000 | 262,348 | 0% | +$15,150 | ||||||
2024-07-18 | GLSI | Thompson Jaye | VP Clinical Reg Affairs | P - Purchase | $16.00 | +1,000 | 261,348 | 0% | +$16,000 | ||||||
2023-10-27 | GLSI | Thompson Jaye | VP Clinical Reg Affairs | P - Purchase | $8.57 | +500 | 260,348 | 0% | +$4,285 | ||||||
2023-09-26 | GLSI | Thompson Jaye | VP Clinical Reg Affairs | P - Purchase | $8.71 | +600 | 259,848 | 0% | +$5,226 | ||||||
2023-07-13 | GLSI | Thompson Jaye | VP Clinical Reg Affairs | P - Purchase | $9.49 | +250 | 259,248 | 0% | +$2,373 | ||||||
2023-04-28 | GLSI | Thompson Jaye | VP Clinical Reg Affairs | P - Purchase | $11.22 | +250 | 258,998 | 0% | +$2,805 | ||||||
2023-04-11 | GLSI | Thompson Jaye | VP Clinical Reg Affairs | P - Purchase | $11.87 | +1,000 | 258,745 | 0% | +$11,870 | ||||||
2023-03-15 | GLSI | Thompson Jaye | VP Clinical Reg Affairs | P - Purchase | $12.71 | +250 | 257,745 | 0% | +$3,178 | ||||||
2023-02-24 | GLSI | Thompson Jaye | VP Clinical Reg Affairs | P - Purchase | $15.40 | +250 | 257,495 | 0% | +$3,849 | ||||||
2023-02-03 | GLSI | Thompson Jaye | VP Clinical Reg Affairs | P - Purchase | $20.84 | +250 | 257,245 | 0% | +$5,210 | ||||||
2023-01-27 | GLSI | Thompson Jaye | VP Clinical Reg Affairs | P - Purchase | $19.20 | +250 | 256,995 | 0% | +$4,800 | ||||||
2023-01-13 | GLSI | Thompson Jaye | VP Clinical Reg Affairs | P - Purchase | $16.50 | +250 | 256,745 | 0% | +$4,125 | ||||||
2022-12-16 | GLSI | Thompson Jaye | VP Clinical Reg Affairs | P - Purchase | $12.94 | +250 | 256,495 | 0% | +$3,235 | ||||||
2022-12-02 | GLSI | Thompson Jaye | VP Clinical Reg Affairs | P - Purchase | $13.98 | +250 | 256,245 | 0% | +$3,495 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |